Screening for Alzheimer's treatment using digital tests and blood tests
Part of Brain & nervous system, Mental health clinical trials.
This study is testing whether simple digital memory tests and blood tests can help find people who might qualify for anti-amyloid treatments (medications that target Alzheimer's-related proteins). It aims to make screening easier and faster, without needing a spinal tap or PET scan.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a patient at the MoCA Clinic (new or seen more than a year ago).
- You have memory or thinking problems (or complaints about them).
- You can understand the study and give your permission to join.
- You have a family member or friend who can help answer questions about your daily life and come to one clinic visit.
- You are not already in another Alzheimer's clinical trial.
- You do not have another condition (like a recent head injury, stroke, or certain dementias) that explains your memory issues.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking for older adults (60–90) who are either cognitively normal, have mild cognitive impairment (MCI), or have mild-to-moderate Alzheimer's dementia. It aims to see how digital tests and blood-based markers relate to brain scans (amyloid and tau PET). You will need a study partner, undergo MRI and PET scans, and give blood samples.
This trial looks for signs of Alzheimer’s disease in the brain by using memory and thinking tests, and related study procedures. It may help researchers find better ways to identify Alzheimer’s-related changes earlier.
This study is looking for a simple blood test to help diagnose Alzheimer's disease earlier and more accurately in a primary care setting. If you are 55 or older with memory concerns, participating could help improve diagnostic methods and may lead to earlier support and treatment.
This study is testing whether a simple blood test can help diagnose Alzheimer's disease and predict how the disease will progress. If you have memory or thinking problems that have been getting worse, you may be able to join.
This study is testing whether simple blood tests can help doctors better understand the type and progression of memory or thinking problems in people with early dementia. It aims to improve confidence in the diagnosis and future outlook.
This study is testing whether a simple blood draw can help spot early signs of Alzheimer's disease. It aims to include people from diverse backgrounds who do not currently have memory problems, which may help make early detection more accessible for everyone.
Hear when a new Mild Cognitive Impairment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.